Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation

BACKGROUND AIMS: Clinical trials for therapeutic angiogenesis use blood- or bone marrow-derived hematopoietic cells, endothelial progenitor cells (EPC) and mesenchymal stromal cells (MSC) for vascular regeneration. Recently concerns have emerged that all three cell types could also contribute to ath...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: ROHDE, EVA, SCHALLMOSER, KATHARINA, REINISCH, ANDREAS, HOFMANN, NICOLE A., PFEIFER, THOMAS, FRÖHLICH, ELEONORE, RECHBERGER, GERALD, LANZER, GERHARD, KRATKY, DAGMAR, STRUNK, DIRK
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173858/
https://ncbi.nlm.nih.gov/pubmed/21128706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2010.536214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky